Details for Patent: 7,211,600
✉ Email this page to a colleague
Summary for Patent: 7,211,600
Title: | Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
Abstract: | The present invention concerns compounds and their use to inhibit the activity of a receptor tyrosine kinase. The invention is preferably used to treat cell proliferative disorders such as cancers characterized by over-activity or inappropriate activity c-kit kinase. |
Inventor(s): | Lipson; Ken (San Mateo, CA), McMahon; Gerald (Kenwood, CA) |
Assignee: | Sugen Inc. (South San Francisco, CA) |
Application Number: | 11/205,474 |
Patent Claim Types: see list of patent claims | Use; Device; |
Drugs Protected by US Patent 7,211,600
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,211,600
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 331514 | ⤷ Try a Trial | |||
Australia | 3436301 | ⤷ Try a Trial | |||
Australia | 784266 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |